Institutional investors hold a majority ownership of PDLI through the 90.81% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2014, these large investors purchased a net $2.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLS FARGO BANK NA (PRIVATE BAN... Bought 1.2 Million shares of PDL BioPharma Inc
ADVISORS ASSET MANAGEMENT, INC. Bought 1.1 Million shares of PDL BioPharma Inc
RENAISSANCE TECHNOLOGIES LLC Bought 1.0 Million shares of PDL BioPharma Inc